bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 1, 2024
Abstract
Mammalian
cancer
cell
lines
are
essential
model
systems
in
biomedical
research.
We
conducted
multi-level
proteomics
analyses
on
54
widely
used
derived
from
various
tissue-of-origins
using
two
prominent
technologies:
mass
spectrometry
(MS)
and
reverse-phase
protein
array
(RPPA).
Our
analysis
identified
10,088
proteins,
33,609
phosphorylation
sites
across
7,289
phosphoproteins,
56,350
site-specific
glycans
16,296
glycosylation
5,966
glycoproteins,
along
with
305
drug-relevant
phosphoprotein
targets.
results
reveal
both
consistent
distinct
patterns
expression
modification
between
MS
RPPA,
underscoring
their
complementary
strengths
as
discovery
tools.
Additionally,
we
features
that
distinguish
tissue
origins
different
line
lineages.
This
dataset
supports
system
selection
for
drug
target-related
studies
vitro
provides
valuable
insights
into
key
signaling
pathways.
Overall,
this
comprehensive
resource
enables
new
opportunities
exploration
biology
offers
significant
value
to
research
communities
focused
biomarker
profiling,
target
discovery,
understanding
mechanisms
diverse
types.
Analytical Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 25, 2025
Nuclear
magnetic
resonance
(NMR)
spectra
of
blood
serum
and
plasma
show
signals
arising
from
metabolites,
lipoproteins,
N-acetyl
methyl
groups
N-glycans
covalently
linked
to
acute-phase
proteins.
These
glycan
often
called
glycoprotein
A
(GlycA)
B
(GlycB)
arise
have
been
proposed
as
biomarkers,
initially
for
cardiovascular
diseases,
but
also
other
inflammatory
conditions.
For
the
detection
resonances,
J-edited,
diffusion,
relaxation
filtered
NMR
spectroscopy
(JEDI)
has
suppress
lipoprotein
signals.
JEDI
is
however
limited
measure
those
acetyl
signals,
whereas
all
cannot
be
observed.
improved
profiling,
pyranose
ring
protons
are
essential.
Here,
we
how
selective
frequency
excitation
combined
with
scalar
coupling
filtering
can
used
dramatically
increase
number
N-glycan
observable
in
samples,
facilitating
glycosylation
profiling
less
than
30
min.
This
approach
grants
sialylation,
galactosylation,
N-acetylglucosaminylation,
fucosylation
dominant
and,
some
extent,
branching
complexity.
Notably,
sialylated
nonsialylated
Lewisx
Lewisa
antigens
antigen
well
established
a
cancer
biomarker,
known
CA19-9.
profiles
nine
isolated
glycoproteins
excellent
agreement
well-established
UHPLC-MS
analysis.
The
method
facilitates
biomarkers
without
need
enzymatic
treatment
or
provides
robust
read-out
exemplified
by
samples
33
patients
hepatocellular
carcinoma.
Analytical Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 11, 2025
A
target-triggered,
enzymatic
cascade-amplified
low-field
nuclear
magnetic
resonance
(LF-NMR)
sensor
was
developed
for
the
detection
of
circulating
tumor
cell
(CTC)
A549.
multifunctional
two-dimensional
bionanomaterial
GDA@GOX&DNA1
designed
as
initiator,
with
Fe3O4@DNA2/Apt
recognition
unit
and
CaO2@MnO2
signal
unit.
When
A549
present,
aptamer
(Apt)
detached
from
unit,
allowing
formation
GDA@GOX&DNA1-DNA2@Fe3O4
triggering
following
reactions:
(1)
glucose
oxidase
(GOX)
catalyzed
reaction
between
substrate
oxygen
(O2)
to
produce
gluconic
acid
hydrogen
peroxide
(H2O2);
(2)
generated
H2O2
reacted
MnO2,
producing
probes
Mn2+
O2;
(3)
CaO2
acid,
generating
H2O2.
These
cyclic
reactions
brought
generation
massive
a
decrease
transverse
relaxation
time
(T2),
resulting
in
LF-NMR
biosensing
CTCs.
Under
optimal
experimental
conditions,
linear
range
limit
(LOD)
were
10–1.0
×
106
6
cells/mL,
respectively.
The
feasibility
reliability
practical
applications
verified
by
using
spiked
whole
blood
samples
containing
cells.
This
study
represents
first
successful
demonstration
an
biosensor
intact
CTCs,
providing
new
tool
clinical
testing
diagnosis.
Discover Oncology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: March 18, 2025
NSUN7,
an
enzyme
responsible
for
the
RNA
m5c
modification,
has
been
recognized
as
a
valuable
indicator
predicting
and
diagnosing
array
of
cancer.
Nevertheless,
there
is
still
scarcity
thorough
analyses
exploring
its
diagnostic,
predictive,
immune
system-related
importance
in
various
types
We
integrated
multiple
publicly
available
databases,
including
TCGA,
TISIDB,
TISCH2,
UALCAN,
to
comprehensively
investigate
role
NSUN7
pan-cancer
across
omics
data
types.
The
research
included
examining
survival
rates,
genetic
mutations,
cell
presence
tumors,
analyzing
differences
gene
expression,
studying
individual
cells,
among
other
things.
expression
showed
increase
12
cancer
decrease
another
was
discovered
be
linked
with
enhanced
rates
bladder
urothelial
carcinoma
(BLCA),
kidney
renal
clear
(KIRC),
papillary
(KIRP),
lung
adenocarcinoma
(LUAD),
pheochromocytoma
paraganglioma
(PCPG),
skin
cutaneous
melanoma
(SKCM),
uveal
(UVM).On
hand,
seemed
have
detrimental
impact
on
prognosis
glioblastoma
multiforme/brain
lower
grade
glioma
(GBMLGG),
adrenocortical
(ACC),acute
myeloid
leukemia
(LAML),
stomach
(STAD),
brain
(LGG).
Furthermore,
our
experimental
validation
confirmed
inhibitory
effect
proliferation
while
elucidating
specific
part
blocking
cycle
progression.
findings
underscore
potential
utility
prognostic
patients
offer
insights
into
mechanisms
underlying
initiation
Breast Cancer Research and Treatment,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 27, 2025
This
study
aims
to
test
the
hypothesis
that
an
enzyme-linked
antibody-lectin
sandwich
assay
for
a
glycovariant
of
CA15-3
can
deliver
better
diagnostic
performance,
defined
by
classification
accuracy,
sensitivity
and
specificity,
breast
cancer
compared
existing
FDA-approved
test.
A
genetically
engineered
lectin
(SubB2M)
specifically
binds
N-glycolylneuraminic
acid
(Neu5Gc)
was
used
as
detection
reagent
in
capture
(neuCA15-3)
assay.
In
case:
control
cohort
equivalence
accuracy
neuCA15-3
determined
IVD
(Elecsys
II,
Roche
Diagnostics).
Classification
AUC
were
81%
0.886
±
0.015
(standard
error,
n
=
567)
Elecsys
55%
0.642
0.023
(n
558),
respectively.
At
threshold
cut-off
serum
concentration
23.6
units/ml,
overall
(compared
comparator
assay,
p
<
0.001).
95%
69.5%,
significantly
greater
than
(11.9%,
concentrations
did
not
vary
with
receptor
subtype
or
comorbidities
tested.
The
performance
substantially
improved
targeting
both
protein
epitope
pan-cancer
glycan
(the
specific
binding
target
SubB2M).
reporter
signal
generated
depends
on
colocalization
antigen
aberrant
sialylation
protein,
thus
increasing
specificity.
presence
multiple
Neu5Gc
lectin-binding
sites
per
glycoprotein
molecule
increases
generation
sensitivity.
inclusion
additional
biomarkers
multivariate
index
format
may
further
increase
cancer.
Oncogene,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 28, 2025
ncRNAs
encapsulated
in
small
extracellular
vesicles
(sEVs)
facilitate
intercellular
communication
and
are
associated
with
tumor
progression.
lncRNA-HOTAIRM1
is
aberrantly
expressed
various
cancers.
However,
HOTAIRM1
expression
its
downstream
ceRNA
network
CTCL
remains
unclear.
In
this
study,
we
found
that
was
reduced
CTCL.
Elevated
inhibited
proliferation
induced
apoptosis
vitro,
resulting
vivo
tumorigenic
capacity.
Whole-transcriptome
sequencing
scRNA-Seq
confirmed
differential
of
HOTAIRM1/miR-196b-5p/MGAT4A
axis
induces
resistance
Mechanistically,
MGAT4A
leads
to
decreased
N-glycosylation
modification
membrane
proteins
Galectin-1
affinity,
thereby
inducing
partial
Galectin-1-induced
apoptosis.
Meanwhile,
benign
CD4
+
T
cells
show
sensitivity
due
their
relatively
higher
expression.
Furthermore,
MGAT4ALow
transformed
MGAT4AHigh
CD4+
into
by
secreting
sEVs
containing
miR-196b-5p,
reducing
binding
resistance.
Engineered
from
HOTAIRM1-overexpressing
contain
elevated
HOTAIRM1,
which
can
specifically
target
malignant
cells,
miR-196b-5p
increased
MGAT4A,
demonstrating
apoptosis-inducing
tumor-suppressive
effects
This
study
identified
changes
modifications
HOTAIRM1-loaded
demonstrated
promising
targeting
therapeutic
Life,
Journal Year:
2025,
Volume and Issue:
15(4), P. 663 - 663
Published: April 17, 2025
Oral
squamous
cell
carcinoma
(OSCC)
is
a
common
type
of
head
and
neck
malignancy
that
represents
significant
global
health
issue.
Sialylations
are
events
in
tumor
transformation,
proliferation,
metastasis,
immune
evasion.
Modifications
sialylation
can
be
detected
by
lectins,
whose
changes
OSCC
have
been
related
to
grade,
invasion,
metastasis.
The
presence
9-O-acetylated
sialic
acid
(Neu5,9Ac2)
cells
its
potential
expression,
modification,
role
unknown.
This
study
aimed
analyze
the
expression
Neu5,9Ac2
using
Macrobrachium
rosenbergii
lectin
(MrL)
recognizes
this
(Neu5Ac)
residue
also
compare
effect
on
SCC-152
line
(CRL-3240,
ATCC)
immortalized
keratinocytes
(HaCaT)
as
control.
We
observed
immunocytochemistry
expressed
more
compared
HaCaT
cells;
specificity
MrL
was
confirmed
after
sialidase
treatment
which
loss
lectin’s
recognition
observed.
electrophoretic
profile
similar
between
both
types;
however,
Western
blot
showed
differences
glycoprotein
patterns
recognized
for
each
type.
increased
proliferation
cells,
well
integrity
morphology
colonies.
Therefore,
our
results
suggest
glycosylated
receptors
could
involved
survival
offers
promising
avenue
developing
diagnostic
prognostic
tools
(tumor
markers)
against
oral
future.